Among treatment-naive adults with advanced HIV disease, integrase inhibitors are a preferred first-line therapy over protease inhibitors.

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...

World Health Organization releases updated recommendations on HIV clinical management: Geneva Thursday, January 8, 2026, 10:00 Hrs [IST] The World Health Organization (WHO) has re ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 ...

Gilead Sciences has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. After comparing two phase 1 integrase strand transfer inhibitors, the Bay Area pharma ...

Researchers at the University of Washington and Fred Hutch found that CARD8, an inflammasome sensor, detects HIV-1 in macrophages during cell-to-cell viral transmissions from infected T cells. HIV can ...

Although there is still no cure for human immunodeficiency virus (HIV), the early introduction of highly active antiretroviral therapy (HAART) has been instrumental in significantly reducing mortality ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...